Literature DB >> 27320392

Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.

J Leland Booth1, Elizabeth S Duggan2, Vineet I Patel3, Marybeth Langer4, Wenxin Wu5, Armin Braun6, K Mark Coggeshall7, Jordan P Metcalf8.   

Abstract

The lung is the entry site for Bacillus anthracis in inhalation anthrax, the most deadly form of the disease. Spores escape from the alveolus to regional lymph nodes, germinate and enter the circulatory system to cause disease. The roles of carrier cells and the effects of B. anthracis toxins in this process are unclear. We used a human lung organ culture model to measure spore uptake by antigen presenting cells (APC) and alveolar epithelial cells (AEC), spore partitioning between these cells, and the effects of B. anthracis lethal toxin and protective antigen. We repeated the study in a human A549 alveolar epithelial cell model. Most spores remained unassociated with cells, but the majority of cell-associated spores were in AEC, not in APC. Spore movement was not dependent on internalization, although the location of internalized spores changed in both cell types. Spores also internalized in a non-uniform pattern. Toxins affected neither transit of the spores nor the partitioning of spores into AEC and APC. Our results support a model of spore escape from the alveolus that involves spore clustering with transient passage through intact AEC. However, subsequent transport of spores by APC from the lung to the lymph nodes may occur. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Anthrax toxin; Bacillus anthracis; Lethal toxin; Lung organ culture; Protective antigen

Mesh:

Substances:

Year:  2016        PMID: 27320392      PMCID: PMC5534360          DOI: 10.1016/j.micinf.2016.06.004

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  36 in total

1.  Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge.

Authors:  David J Banks; Moshe Barnajian; Francisco J Maldonado-Arocho; Ana M Sanchez; Kenneth A Bradley
Journal:  Cell Microbiol       Date:  2005-08       Impact factor: 3.715

2.  Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.

Authors:  Marybeth Langer; Elizabeth Stewart Duggan; John Leland Booth; Vineet Indrajit Patel; Ryan A Zander; Robert Silasi-Mansat; Vijay Ramani; Tibor Zoltan Veres; Frauke Prenzler; Katherina Sewald; Daniel M Williams; Kenneth Mark Coggeshall; Shanjana Awasthi; Florea Lupu; Dennis Burian; Jimmy Dale Ballard; Armin Braun; Jordan Patrick Metcalf
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

3.  Group B Streptococcus (GBS) disrupts by calpain activation the actin and microtubule cytoskeleton of macrophages.

Authors:  Katia Fettucciari; Flavia Quotadamo; Rosina Noce; Camilla Palumbo; Andrea Modesti; Emanuela Rosati; Roberta Mannucci; Andrea Bartoli; Pierfrancesco Marconi
Journal:  Cell Microbiol       Date:  2011-03-18       Impact factor: 3.715

4.  Entry of Bacillus anthracis spores into epithelial cells is mediated by the spore surface protein BclA, integrin α2β1 and complement component C1q.

Authors:  Qiong Xue; Chunfang Gu; Jose Rivera; Magnus Höök; Xiwu Chen; Ambra Pozzi; Yi Xu
Journal:  Cell Microbiol       Date:  2010-12-28       Impact factor: 3.715

5.  Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells.

Authors:  Y Singh; S H Leppla; R Bhatnagar; A M Friedlander
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

6.  Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.

Authors:  Sara Heninger; Melissa Drysdale; Julie Lovchik; Julie Hutt; Mary F Lipscomb; Theresa M Koehler; C Rick Lyons
Journal:  Infect Immun       Date:  2006-08-21       Impact factor: 3.441

7.  Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.

Authors:  Julie A Lovchik; Melissa Drysdale; Theresa M Koehler; Julie A Hutt; C Rick Lyons
Journal:  Infect Immun       Date:  2012-04-23       Impact factor: 3.441

8.  Potential dissemination of Bacillus anthracis utilizing human lung epithelial cells.

Authors:  Brooke H Russell; Ranga Vasan; Douglas R Keene; Theresa M Koehler; Yi Xu
Journal:  Cell Microbiol       Date:  2007-12-06       Impact factor: 3.715

9.  Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin.

Authors:  Wenxin Wu; Harshini Mehta; Kaushik Chakrabarty; J Leland Booth; Elizabeth S Duggan; Krupa B Patel; Jimmy D Ballard; K Mark Coggeshall; Jordan P Metcalf
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

10.  Bacillus anthracis spore interactions with mammalian cells: relationship between germination state and the outcome of in vitro.

Authors:  Ian M Gut; Batcha Tamilselvam; Angela M Prouty; Bojana Stojkovic; Stephanie Czeschin; Wilfred A van der Donk; Steven R Blanke
Journal:  BMC Microbiol       Date:  2011-02-28       Impact factor: 3.605

View more
  3 in total

Review 1.  Airway Macrophage and Dendritic Cell Subsets in the Resting Human Lung.

Authors:  Vineet Indrajit Patel; Jordan Patrick Metcalf
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

2.  Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax.

Authors:  Chad W Stratilo; Scott Jager; Melissa Crichton; James D Blanchard
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

3.  Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes.

Authors:  Vineet I Patel; J Leland Booth; Mikhail Dozmorov; Brent R Brown; Jordan P Metcalf
Journal:  Toxins (Basel)       Date:  2020-07-20       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.